| Literature DB >> 6744338 |
L T Malden, A S Coates, G W Milton, W H McCarthy, J A Levi, R L Woods, M J Byrne, P M Reynolds, R M Fox, D W Hedley.
Abstract
Fifty-one patients (43 evaluable) with malignant melanoma were treated with mitolactol in an intermittent oral schedule. There were four objective tumor responses, all occurring in patients previously treated with dacarbazine.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6744338
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960